Annual CFO
-$5.20 M
+$5.43 M+51.06%
01 September 2023
Summary:
Bright Minds Biosciences annual cash flow from operations is currently -$5.20 million, with the most recent change of +$5.43 million (+51.06%) on 01 September 2023. During the last 3 years, it has risen by +$584.50 thousand (+10.10%). DRUG annual CFO is now -2325.30% below its all-time high of -$214.60 thousand, reached on 30 September 2020.DRUG Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$193.00 K
+$795.60 K+132.03%
01 June 2024
Summary:
Bright Minds Biosciences quarterly cash flow from operations is currently $193.00 thousand, with the most recent change of +$795.60 thousand (+132.03%) on 01 June 2024. Over the past year, it has increased by +$1.07 million (+122.10%). DRUG quarterly CFO is now at all-time high.DRUG Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$1.89 M
+$1.44 M+43.25%
01 June 2024
Summary:
Bright Minds Biosciences TTM cash flow from operations is currently -$1.89 million, with the most recent change of +$1.44 million (+43.25%) on 01 June 2024. Over the past year, it has increased by +$3.32 million (+63.75%). DRUG TTM CFO is now -4074.12% below its all-time high of -$45.20 thousand, reached on 31 December 2019.DRUG TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DRUG Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +122.1% | +63.8% |
| 3 y3 years | +10.1% | +110.9% | +67.4% |
| 5 y5 years | - | - | - |
DRUG Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +51.1% | at high | +104.9% | at high | +82.9% |
| 5 y | 5 years | -2325.3% | +51.1% | at high | +104.9% | -4074.1% | +82.9% |
| alltime | all time | -2325.3% | +51.1% | at high | +104.9% | -4074.1% | +82.9% |
Bright Minds Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $193.00 K(-132.0%) | -$1.89 M(-43.3%) |
| Mar 2024 | - | -$602.60 K(-0.2%) | -$3.32 M(-13.6%) |
| Dec 2023 | - | -$603.90 K(-30.8%) | -$3.85 M(-26.1%) |
| Sept 2023 | -$5.20 M(-51.1%) | -$873.20 K(-29.9%) | -$5.20 M(-13.3%) |
| June 2023 | - | -$1.25 M(+10.6%) | -$6.00 M(-13.5%) |
| Mar 2023 | - | -$1.13 M(-42.6%) | -$6.94 M(-20.0%) |
| Dec 2022 | - | -$1.96 M(+17.5%) | -$8.67 M(-18.5%) |
| Sept 2022 | -$10.64 M | -$1.67 M(-23.6%) | -$10.64 M(-1.0%) |
| June 2022 | - | -$2.18 M(-23.5%) | -$10.74 M(-2.6%) |
| Mar 2022 | - | -$2.86 M(-27.3%) | -$11.03 M(+18.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$3.93 M(+121.3%) | -$9.30 M(+60.6%) |
| Sept 2021 | -$5.79 M(+2597.7%) | - | - |
| Sept 2021 | - | -$1.78 M(-28.1%) | -$5.79 M(+38.7%) |
| June 2021 | - | -$2.47 M(+120.1%) | -$4.17 M(+147.5%) |
| Mar 2021 | - | -$1.12 M(+166.2%) | -$1.69 M(+185.3%) |
| Dec 2020 | - | -$421.70 K(+166.1%) | -$591.00 K(+175.5%) |
| Sept 2020 | -$214.60 K | - | - |
| Sept 2020 | - | -$158.50 K(-1049.1%) | -$214.50 K(+283.0%) |
| June 2020 | - | $16.70 K(-160.7%) | -$56.00 K(-23.0%) |
| Mar 2020 | - | -$27.50 K(-39.2%) | -$72.70 K(+60.8%) |
| Dec 2019 | - | -$45.20 K | -$45.20 K |
FAQ
- What is Bright Minds Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly CFO year-on-year change?
- What is Bright Minds Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Bright Minds Biosciences?
- What is Bright Minds Biosciences TTM CFO year-on-year change?
What is Bright Minds Biosciences annual cash flow from operations?
The current annual CFO of DRUG is -$5.20 M
What is the all time high annual CFO for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual cash flow from operations is -$214.60 K
What is Bright Minds Biosciences quarterly cash flow from operations?
The current quarterly CFO of DRUG is $193.00 K
What is the all time high quarterly CFO for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly cash flow from operations is $193.00 K
What is Bright Minds Biosciences quarterly CFO year-on-year change?
Over the past year, DRUG quarterly cash flow from operations has changed by +$1.07 M (+122.10%)
What is Bright Minds Biosciences TTM cash flow from operations?
The current TTM CFO of DRUG is -$1.89 M
What is the all time high TTM CFO for Bright Minds Biosciences?
Bright Minds Biosciences all-time high TTM cash flow from operations is -$45.20 K
What is Bright Minds Biosciences TTM CFO year-on-year change?
Over the past year, DRUG TTM cash flow from operations has changed by +$3.32 M (+63.75%)